Literature DB >> 19820449

Fifth Warren K. Sinclair Keynote Address: Issues in quantifying the effects of low-level radiation.

Dudley T Goodhead1.   

Abstract

Health risks from exposure to high doses of ionizing radiation are well characterized from epidemiological studies. Uncertainty and controversy remain for extension of these risks to the low doses and low dose rates of particular relevance in the workplace, in medical diagnostics and screening, and from background radiations. In order to make such extrapolations, a number of concepts have been developed for radiation protection, partly on the basis of assumed processes in the mechanisms of radiation carcinogenesis. Included amongst these are the assumptions of a linear no-threshold dose response and simple scaling factors for dose rate and radiation quality. With a progressive reduction in recommended dose limits over the past half century, these approaches have had considerable success in protecting humans. But do they go far enough or, conversely, are they overprotective? Four selected underlying aspects are considered. It is concluded that (1) even the lowest dose of radiation has the capability to cause complex DNA damage that can lead to a variety of permanent cellular changes; (2) the unique clustered characteristics of radiation damage, even at very low doses, enable it to stand out above the much larger quantity of endogenous DNA damage; (3) although a chromosome aberration may represent the rate-limiting initiating event for carcinogenesis, as is often assumed, direct evidence is still lacking; and (4) the extensive influence that dicentric aberrations have had on guiding extrapolations for radiation protection may be substantially misleading. Finally, some comments are offered on aspects that lie outside the current paradigm.

Entities:  

Mesh:

Year:  2009        PMID: 19820449     DOI: 10.1097/HP.0b013e3181ae8acf

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  8 in total

1.  Low-dose radiation accelerates aging of the T-cell receptor repertoire in CBA/Ca mice.

Authors:  Serge M Candéias; Justyna Mika; Paul Finnon; Tom Verbiest; Rosemary Finnon; Natalie Brown; Simon Bouffler; Joanna Polanska; Christophe Badie
Journal:  Cell Mol Life Sci       Date:  2017-06-30       Impact factor: 9.261

2.  DNA end resection is needed for the repair of complex lesions in G1-phase human cells.

Authors:  Nicole B Averbeck; Oliver Ringel; Maren Herrlitz; Burkhard Jakob; Marco Durante; Gisela Taucher-Scholz
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

3.  Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer.

Authors:  Robert Stainforth; Jan Schuemann; Aimee L McNamara; Ruth C Wilkins; Vinita Chauhan
Journal:  Int J Radiat Biol       Date:  2020-09-30       Impact factor: 2.694

4.  Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia.

Authors:  C-H Olme; R Finnon; N Brown; S Kabacik; S D Bouffler; C Badie
Journal:  Leuk Res       Date:  2013-06-25       Impact factor: 3.156

Review 5.  Effects of Charged Particles on Human Tumor Cells.

Authors:  Kathryn D Held; Hidemasa Kawamura; Takuya Kaminuma; Athena Evalour S Paz; Yukari Yoshida; Qi Liu; Henning Willers; Akihisa Takahashi
Journal:  Front Oncol       Date:  2016-02-12       Impact factor: 6.244

6.  What we know and what we don't know about cancer risks associated with radiation doses from radiological imaging.

Authors:  D J Brenner
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

7.  Dependence and independence of survival parameters on linear energy transfer in cells and tissues.

Authors:  Koichi Ando; Dudley T Goodhead
Journal:  J Radiat Res       Date:  2016-07-05       Impact factor: 2.724

8.  Cytogenetic damage analysis in mice chronically exposed to low-dose internal tritium beta-particle radiation.

Authors:  Sandrine Roch-Lefèvre; Eric Grégoire; Cécile Martin-Bodiot; Matthew Flegal; Amélie Fréneau; Melinda Blimkie; Laura Bannister; Heather Wyatt; Joan-Francesc Barquinero; Laurence Roy; Mohamed Benadjaoud; Nick Priest; Jean-René Jourdain; Dmitry Klokov
Journal:  Oncotarget       Date:  2018-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.